Shao-Lee Lin Insider Profile

4 Followers
Shao-Lee Lin, EVP, Head of R&D and CSO at Horizon Therapeutics, holds 109.67K shares in Horizon Therapeutics (Ticker: HZNP), holds ― shares in Principia Biopharma (Ticker: PRNB), holds ― shares in Surrozen (Ticker: SRZN).
tipranks
Shao-Lee Lin

Shao-Lee Lin
Horizon Therapeutics (HZNP)
EVP, Head of R&D and CSO

Ranked #38,795 out of 99,218 Corporate Insiders

Profitable Transactions

100%
2 out of 2 Profitable Transactions

Average Return

+20.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$21M
100.00%
0.00%
0.00%
A breakdown of Shao-Lee Lin's holdings

Insider Roles

ACELYRIN, INC.
(SLRN)
CEO, Director
Surrozen
(SRZN)
Director
Third Harmonic Bio, Inc.
(THRD)
Director
Roles that Shao-Lee Lin holds in companies

Most Profitable Insider Trade

Stock:
ACELYRIN, INC.
(SLRN)
Rating:Informative Sell
Date:Feb 22, 2024 - Today
Return:+25.20%
The most profitable trade made by Shao-Lee Lin

Shao-Lee Lin's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
HZNP
Horizon Therapeutics
Jan 23, 2020
Uninformative Buy
$12.75M
PRNB
Principia Biopharma
Surrozen
Director
Third Harmonic Bio, Inc.
Director
ACELYRIN, INC.
Apr 03, 2024
CEO, Director
Informative Sell
65.94K
$20.71M
List of latest transactions for each holding click on a transaction to see Shao-Lee Lin's performance on stock

Shao-Lee Lin insider profile FAQ

What is the percentage of profitable transactions made by Shao-Lee Lin?
The percentage of profitable transactions made by Shao-Lee Lin is 100%.
    What is the average return per transaction made by Shao-Lee Lin?
    The average return per transaction made by Shao-Lee Lin is 20.20%.
      What stocks does Shao-Lee Lin hold?
      Shao-Lee Lin holds: HZNP, PRNB, SRZN, THRD, SLRN stocks.
        What was Shao-Lee Lin’s latest transaction?
        Shao-Lee Lin latest transaction was an Uninformative Buy of ―.
          What was Shao-Lee Lin's most profitable transaction?
          Shao-Lee Lin’s most profitable transaction was an Informative Sell of SLRN stock on February 22, 2024. The return on the trade was 25.20%.
            What is Shao-Lee Lin's role in Horizon Therapeutics?
            Shao-Lee Lin's role in Horizon Therapeutics is EVP, Head of R&D and CSO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.